Pro 2014-008 (Announcement of Jianfeng Group on Cancellation of Subsidiary)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2014-008
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Cancellation of Subsidiary
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
1. Overview
Company At the 14th meeting of the 8th Board of Directors held on April 11, 2014, the "Proposal on Cancellation of Zhejiang Jinhua Zhongneng Products Co., Ltd." The voting result: 9 votes in favor, 0 votes against, and 0 abstentions.
Basic Information of 2. Zhongneng Products
Zhejiang Jinhua Zhongneng Products Co., Ltd. (hereinafter referred to as Zhongneng Products ) is a wholly-owned subsidiary of the company's holding subsidiary Zhejiang Jianfeng International Trade Co., Ltd. (hereinafter referred to as Jianfeng International Trade Co., Ltd. ), which was established on December 24, 2012, the company has a registered capital of 10 million yuan and was registered and established in Wucheng Branch of Jinhua Administration for Industry and Commerce. Its domicile is 88 Wujiang East Road, Jinhua City, and its business license registration number is 330702000076017.
Business Scope: Purchase and sales of chemical raw materials and products, pharmaceutical intermediates (except hazardous chemicals, precursor chemicals, monitoring chemicals); procurement and sales of rubber, Wujinjiaodian, daily necessities, wood pulp, paper, steel, non-ferrous metal materials, textiles, clothing, primary edible agricultural products, handicrafts (except cultural relics), building decoration materials, mechanical equipment, instruments and meters, packaging materials, communication cables and equipment (except radio); logistics supply chain consulting services; Business consulting service activities permitted by national laws and policies; domestic and international freight forwarding business. (The above business scope does not include projects prohibited, restricted and permitted by national laws.)
In 2013, Zhongneng Products realized operating income of 87.9136 million yuan and net profit of -106200 yuan. By the end of 2013, total assets were 10.3488 million yuan, net assets were 9.7963 million yuan and liabilities were 552500 yuan.
3. The main business activity of Zhongneng Products
Zhongneng Products is the spot trade of PVC, and PVC is a mature chemical product. Large-scale PVC traders use the combination of futures and spot. In addition, for some relatively large-scale and well-known PCV production enterprises, there are basically long-term cooperative agents in East China. Zhongneng products can only obtain the source of goods through agents. The purchase price is relatively high and there is no advantage in the competition.
Impact of 4. on the Company
According to the operation of Zhongneng Products, the Board of Directors believes that its PVC trading business has no obvious advantages and is difficult to become bigger and stronger. According to the company's implementation of flat control mode, reduce the subsidiary management level, reduce the management cost requirements. The Board of Directors made a resolution to cancel the company, and the assets and related business of Zhongneng Property were undertaken by its parent company, Peak International Trade. The existing assets of Zhongneng Property are in clear condition, the proportion of its business income to the company's overall operating income is not high, the profit and loss is small, the cancellation of Zhongneng Property will not have a significant impact on the company's overall assets and profitability.
The independent directors of the company issued an independent opinion for this, and believed that the formation of the resolution complied with the "Company Law", the company's "Articles of Association" and other relevant regulations, and did not harm the interests of small and medium shareholders.
5. Reference Document
Resolution of the 14th Meeting of the 8th Board of Directors of the Company;
hereby announces
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
April 15, 2014
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page